日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identification of bacteria-derived HLA-bound peptides in melanoma

黑色素瘤中细菌来源的HLA结合肽的鉴定

Kalaora, Shelly; Nagler, Adi; Nejman, Deborah; Alon, Michal; Barbolin, Chaya; Barnea, Eilon; Ketelaars, Steven L C; Cheng, Kuoyuan; Vervier, Kevin; Shental, Noam; Bussi, Yuval; Rotkopf, Ron; Levy, Ronen; Benedek, Gil; Trabish, Sophie; Dadosh, Tali; Levin-Zaidman, Smadar; Geller, Leore T; Wang, Kun; Greenberg, Polina; Yagel, Gal; Peri, Aviyah; Fuks, Garold; Bhardwaj, Neerupma; Reuben, Alexandre; Hermida, Leandro; Johnson, Sarah B; Galloway-Peña, Jessica R; Shropshire, William C; Bernatchez, Chantale; Haymaker, Cara; Arora, Reetakshi; Roitman, Lior; Eilam, Raya; Weinberger, Adina; Lotan-Pompan, Maya; Lotem, Michal; Admon, Arie; Levin, Yishai; Lawley, Trevor D; Adams, David J; Levesque, Mitchell P; Besser, Michal J; Schachter, Jacob; Golani, Ofra; Segal, Eran; Geva-Zatorsky, Naama; Ruppin, Eytan; Kvistborg, Pia; Peterson, Scott N; Wargo, Jennifer A; Straussman, Ravid; Samuels, Yardena

A genome-wide CRISPR screen identifies FBXO42 involvement in resistance toward MEK inhibition in NRAS-mutant melanoma

全基因组 CRISPR 筛选确定 FBXO42 与 NRAS 突变黑色素瘤对 MEK 抑制的抗性有关

Adi Nagler, David W Vredevoogd, Michal Alon, Phil F Cheng, Sophie Trabish, Shelly Kalaora, Rand Arafeh, Victoria Goldin, Mitchell P Levesque, Daniel S Peeper, Yardena Samuels

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

UVB诱导的肿瘤异质性会降低黑色素瘤的免疫反应。

Yochai Wolf ,Osnat Bartok ,Sushant Patkar ,Gitit Bar Eli ,Sapir Cohen ,Kevin Litchfield ,Ronen Levy ,Alejandro Jiménez-Sánchez ,Sophie Trabish ,Joo Sang Lee ,Hiren Karathia ,Eilon Barnea ,Chi-Ping Day ,Einat Cinnamon ,Ilan Stein ,Adam Solomon ,Lital Bitton ,Eva Pérez-Guijarro ,Tania Dubovik ,Shai S Shen-Orr ,Martin L Miller ,Glenn Merlino ,Yishai Levin ,Eli Pikarsky ,Lea Eisenbach ,Arie Admon ,Charles Swanton ,Eytan Ruppin ,Yardena Samuels